For Which Cancer to Avoid taking Supplement Graviola?

Описание к видео For Which Cancer to Avoid taking Supplement Graviola?

🌟 Read More:https://addon.life/2022/11/13/for-whi...

Nutritional supplements and extracts like Graviola have benefits and are used by cancer patients and those at-genetic risk of cancer. There is limited or hardly any clinical data available for use of nutritional supplements and foods in cancer patients. Generating clinical evidence of efficacy for cancer through a randomized clinical trial is further infeasible due to variations in genetics and cancer chemotherapy treatments across cancer patients. Hence a different and new approach is needed to find out for which cancers you should not take Graviola supplement and why should not take them?

Taking Graviola extracts or nutritional supplements may benefit Primary Hodgkin Lymphoma patients on Bleomycin treatment over Chitrak nutritional supplements. But Graviola supplements or Graviola extracts offer less benefit if on Radiation treatment for Primary Urethral Squamous Cell Carcinoma compared to Dandelion. Similarly, taking nutritional supplements Graviola may benefit healthy individuals who are at genetic risk of cancer due to mutation of gene HRAS over Linoleic Acid. But avoid nutritional supplements Graviola when at genetic risk of cancer due to mutation of gene MEN1.

Whenever there are changes in chemotherapy treatments or cancer tissue genetics – the nutrition may change and hence needs to be re-evaluated. Do consider factors like cancer indication, ongoing chemotherapy treatments and nutritional supplements, age, gender, weight, height, lifestyle and genetics for personalization of nutrition.

https://addon.life/onboarding/
☝ Create Personalized Nutrition Plan for Cancer

🌟 Here is an example of nutrition planning https://addon.life/sample-report/
✅ Facebook:   / addonforcancer  
✅ Twitter:   / addonforcancer  
✅ Instagram:   / addonforcancer  
✅ Pinterest:   / addonforcancer  

✉ Email: [email protected] | © Copyright 2022, addon.life.

Комментарии

Информация по комментариям в разработке